More Information on Disease State and Trial Options for Patients with Advanced Non-Small Cell Lung Cancer; Evaluating Automated and Manual Workflows in cfDNA Extraction
Biodesix, in partnership with BioRad and Qiagen, presents data from new studies at AMP.